ADVA Biotechnologies
Mr. Lindner was the maintenance manager at ATVIO Biotech where he was part of the innovative bioreactor development team. Furthermore, Mr. Lindner has over 6 years of experience in the maintenance of cGMP production facilities at Pluristem Therapeutics and deep knowledge and expertise in Bioreactors.
ADVA Biotechnologies
ADVA Biotechnology develops enabling technologies for cell therapy manufacturing. The company has developed ADVA X3, a robust, modular cell-manufacturing cGMP system based on a single-use end-to-end solution.ADVA X3 enables autologous cell therapy manufacturing at the bedside, allowing optimization, tight quality assurance, improved availability,reduced time to market, and significant cost reduction. The automated platform is designed to enable autologous manufacturing of additional types of cells with a change in the disposable chamber, allowing efficiency and flexibility with a long pipeline of products.